Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 10:15 am Sale |
2021-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
RTW INVESTMENTS LP | 0 0.000% |
-9 (Position Closed) |
Filing History |
| 2023-02-14 10:13 am Sale |
2022-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
RTW INVESTMENTS LP | 0 0.000% |
-7,027,725 (Position Closed) |
Filing History |
| 2023-02-14 10:12 am Sale |
2022-12-31 | 13G | MacroGenics, Inc. MGNX |
RTW INVESTMENTS LP | 0 0.000% |
-3,975,554 (Position Closed) |
Filing History |
| 2023-02-14 10:11 am Sale |
2022-12-31 | 13G | Vericel Corporation VCEL |
RTW INVESTMENTS LP | 3,099,904 6.600% |
-1,417,666 (-31.38%) |
Filing History |
| 2023-02-14 10:11 am Sale |
2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
RTW INVESTMENTS LP | 0 0.000% |
-2,520,076 (Position Closed) |
Filing History |
| 2023-02-14 10:10 am Purchase |
2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
RTW INVESTMENTS LP | 3,966,915 5.700% |
3,966,915 (New Position) |
Filing History |
| 2023-02-14 10:10 am Sale |
2022-12-31 | 13G | TELA Bio, Inc. TELA |
RTW INVESTMENTS LP | 390,364 2.000% |
-1,009,322 (-72.11%) |
Filing History |
| 2023-02-14 10:10 am Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW INVESTMENTS LP | 2,067,824 6.900% |
-118,500 (-5.42%) |
Filing History |
| 2023-02-14 10:09 am Purchase |
2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
RTW INVESTMENTS LP | 3,643,114 6.300% |
3,643,114 (New Position) |
Filing History |
| 2023-02-14 10:09 am Purchase |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW INVESTMENTS LP | 2,548,125 9.600% |
534,524 (+26.55%) |
Filing History |
| 2023-02-14 10:08 am Sale |
2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW INVESTMENTS LP | 3,084,215 6.500% |
-837,364 (-21.35%) |
Filing History |
| 2023-02-14 10:08 am Purchase |
2022-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW INVESTMENTS LP | 3,870,981 9.800% |
226,733 (+6.22%) |
Filing History |
| 2023-02-14 10:08 am Purchase |
2022-12-31 | 13G | C4 Therapeutics, Inc. CCCC |
RTW INVESTMENTS LP | 2,819,472 5.800% |
324,507 (+13.01%) |
Filing History |
| 2023-02-14 10:08 am Sale |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW INVESTMENTS LP | 0 0.000% |
-2,353,015 (Position Closed) |
Filing History |
| 2023-02-14 10:07 am Purchase |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
RTW INVESTMENTS LP | 4,356,920 9.500% |
1,375,960 (+46.16%) |
Filing History |
| 2023-02-14 10:07 am Purchase |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW INVESTMENTS LP | 2,980,482 6.900% |
2,980,482 (New Position) |
Filing History |
| 2023-02-14 10:07 am Purchase |
2022-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
RTW INVESTMENTS LP | 5,106,341 9.900% |
2,243,143 (+78.34%) |
Filing History |
| 2023-02-14 10:06 am Purchase |
2022-12-31 | 13G | Immunic, Inc. IMUX |
RTW INVESTMENTS LP | 3,861,290 8.700% |
2,145,820 (+125.09%) |
Filing History |
| 2023-02-14 10:06 am Sale |
2022-12-31 | 13G | La Jolla Pharmaceutical Company LJPC |
RTW INVESTMENTS LP | 0 0.000% |
-2,590,932 (Position Closed) |
Filing History |
| 2023-02-14 10:06 am Sale |
2022-12-31 | 13G | IVERIC bio, Inc. ISEE |
RTW INVESTMENTS LP | 821,288 0.600% |
-5,901,336 (-87.78%) |
Filing History |